Baclofen, sold in France under the name Lioresal, is a muscle relaxant usually prescribed to fight against “spastic contractures of multiple sclerosis, medullary or cerebral affections”.
Three months ago, this drug received a temporary recommendation for use (RTU) from the Medicines Agency (ANSM) to be able to be used in the treatment of alcohol dependence, “after failure of other available treatments “.
But for lack of reimbursement, the financial impact of the treatment could be a brake for some patients because it is sometimes necessary to take the dose of one box of 30 tablets per day.
This brake has just been lifted, because the cabinet of the Minister of Health, Marisol Touraine, confirmed to Le Figaro that a decree will be published “in the coming days” in favor of the reimbursement of Baclofen in the treatment of alcohol -addiction.
The drug should be supported at 30%
Baclofen is prescribed for the following two indications: helping to maintain abstinence after withdrawal in alcohol-dependent patients and major reduction of alcohol consumption to the low level of consumption in alcohol-dependent patients. high risk.
According to certain information from Philippe Jaury, coordinator of the clinical trial on Baclofen, the box of 30 tablets of 10mg, which costs 5 to 7 euros, would be covered at 30% by Social Security.
